+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
EUSA Pharma Ltd - logo

Founded in 2006, EUSA Pharma is a specialty pharmaceutical company that focuses on oncology and oncology supportive care, as well as pain control and critical care products. The company’s products include Caphosol for the treatment of oral mucositis; ProstaScint for imaging the extent and spread of prostate cancer; Quadramet for the treatment of pain in patients and a variety of others. The company is based in Langhorne, Pennsylvania. EUSA Pharma operates as a subsidiary of Essex Bidco Ltd.

Coronavirus Disease 2019 (COVID-19) Vaccines and Drugs Contract Pharmaceutical Development and Manufacturing Relationships - Product Thumbnail Image

Coronavirus Disease 2019 (COVID-19) Vaccines and Drugs Contract Pharmaceutical Development and Manufacturing Relationships

  • Report
  • September 2021
  • 52 Pages
From
Multiple Myeloma (Kahler Disease) (Oncology) - Drugs in Development, 2021 - Product Thumbnail Image

Multiple Myeloma (Kahler Disease) (Oncology) - Drugs in Development, 2021

  • Report
  • December 2021
  • 2980 Pages
From
Global Coronavirus Partnering 2015-2022 - Product Thumbnail Image

Global Coronavirus Partnering 2015-2022

  • Report
  • April 2022
  • 800 Pages
From
Fotivda (tivozanib; AVEO Oncology/EUSA Pharma/Kyowa Hakko Kirin) Drug Overview 2019 - Product Thumbnail Image

Fotivda (tivozanib; AVEO Oncology/EUSA Pharma/Kyowa Hakko Kirin) Drug Overview 2019

  • Report
  • March 2019
  • 16 Pages
Neuroblastoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Neuroblastoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 1084 Pages
From
Global Genetic Disorders Partnering 2015-2022: Deal Trends, Players and Financials - Product Thumbnail Image

Global Genetic Disorders Partnering 2015-2022: Deal Trends, Players and Financials

  • Report
  • April 2022
  • 450 Pages
From
Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2022 - Product Thumbnail Image

Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2022

  • Report
  • April 2022
  • 500 Pages
From
Acute Respiratory Distress Syndrome (Respiratory) - Drugs in Development, 2021 - Product Thumbnail Image

Acute Respiratory Distress Syndrome (Respiratory) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
From
Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2016-2021 - Product Thumbnail Image

Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2016-2021

  • Report
  • October 2021
  • 2500 Pages
From
Amyloidosis (Metabolic Disorder) - Drugs in Development, 2021 - Product Thumbnail Image

Amyloidosis (Metabolic Disorder) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
From
Castleman Disease Treatment Market Research Report by Disease Type (Multicentric Castleman's Disease and Unicentric Castleman's Disease), Indication, Therapy, Application, State - United States Forecast to 2027 - Cumulative Impact of COVID-19 - Product Thumbnail Image

Castleman Disease Treatment Market Research Report by Disease Type (Multicentric Castleman's Disease and Unicentric Castleman's Disease), Indication, Therapy, Application, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • Report
  • April 2022
  • 116 Pages
From
Castleman Disease Treatment Market Research Report by Disease Type, Indication, Therapy, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 - Product Thumbnail Image

Castleman Disease Treatment Market Research Report by Disease Type, Indication, Therapy, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • Report
  • April 2022
  • 217 Pages
From
Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2016-2022 - Product Thumbnail Image

Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2016-2022

  • Report
  • April 2022
  • 2500 Pages
From
Europe Kidney Cancer Therapeutics & Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Europe Kidney Cancer Therapeutics & Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 68 Pages
From
Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015 to 2022 - Product Thumbnail Image

Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015 to 2022

  • Report
  • April 2022
  • 600 Pages
From
Neuroblastoma - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Neuroblastoma - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
From
Global Castleman Disease Treatment Market (2021-2026) by Disease Type, Indication, Treatment Type, End Users, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis - Product Thumbnail Image

Global Castleman Disease Treatment Market (2021-2026) by Disease Type, Indication, Treatment Type, End Users, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • Report
  • June 2021
  • 189 Pages
From
Castleman Disease - Pipeline Insight - 2020 - Product Thumbnail Image

Castleman Disease - Pipeline Insight - 2020

  • Clinical Trials
  • November 2020
  • 40 Pages
From
Global Oral Mucositis Drugs Market Research Report 2022 (Status and Outlook) - Product Thumbnail Image

Global Oral Mucositis Drugs Market Research Report 2022 (Status and Outlook)

  • Report
  • May 2022
  • 114 Pages
From
Global Xerostomia (Dry Mouth) Therapeutics Market 2019-2025 - Product Thumbnail Image

Global Xerostomia (Dry Mouth) Therapeutics Market 2019-2025

  • Report
  • June 2020
From
Loading Indicator